Clements RT#*, Fuller LE#*, Kraemer KR, Radomski SA*, Hunter-Chang S, Hall WC*, Kalantar AA*, and Kraemer BR (2022). “Quantification of Neurite Degeneration with Enhanced Accuracy and Efficiency in an in vitro Model of Parkinson’s disease, eNeuro. 9 (2) ENEURO.0327-21.2022; DOI: https://doi.org/10.1523/ENEURO.0327-21.2022
Kraemer BR and Carter BD. (2021) Neurotrophin Receptor Signaling. In: Jez J. et el. (Eds). Encyclopedia of Biological Chemistry (Third Edition), Volume 6, (pp.187-200). Cambridge, MA: Elsevier. https://doi.org/10.1016/B978-0-12-819460-7.00310-8
Kraemer BR, Clements RT*, Escobedo CM, Nelson KS*, Waugh CD*, Elliott AS*, Hall WC*, and Schemanski MT* (2021) “c-Jun N-terminal Kinase Mediates Ligand-independent p75NTR Signaling in Mesencephalic Cells Subjected to Oxidative Stress” Neuroscience. 453:222-236. doi:10.1016/j.neuroscience.2020.11.036.
Mobley BC, Kwon M, Kraemer BR, Hickman FE, Qiao J, Chung DH, Carter BD (2015). “Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis.” PLoS One. 10(7):e0133897.
Kraemer BR, Snow JP*, Vollbrecht PJ, Pathak A, Valentine WM, Deutch AY, and Carter BD (2014). “A Role for the p75 Neurotrophin Receptor in Axonal Degeneration and Apoptosis Induced by Oxidative Stress” Journal of Biological Chemistry, 289(31):21205-16.
Kraemer BR, Yoon SO, and Carter BD (2014). “The Biological Functions and Signaling Mechanisms of the p75 Neurotrophin Receptor”. in Neurotrophic Factors, Handbook of Experimental Pharmacology (Book 220, Carter BD and Lewin GR, ed.), Springer. pp 121-164